QbD Group, a life science consultancy and software leader active in the development, clinical, regulatory & compliance, production and distribution for companies active in ATMP, Biotech, Medical Devices, In Vitro Diagnostics, Digital Health and Pharma, has a clear roadmap for inorganic growth.
The company from Wilrijk, Belgium, has almost 500 full-time employees and operates worldwide. While they previously worked with established local partners, they wanted to switch to a faster, global approach. That’s when they found out about Fintalent.
Fintalent delivered an experienced M&A leader with relevant industry experience. The contract was signed within 2 weeks.
The goal was to deliver a long- and shortlist of potential acquisition targets.
6 weeks after the first contact with Fintalent, QbD Group started leading the first conversations with potential targets, and are very optimistic about the outcome of the project.